RUBIUS THERAPEUTICS INC - COM (RUBY) Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2018 to Q2 2023

Type / Class
Equity / COM
Symbol
RUBY
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of RUBIUS THERAPEUTICS INC - COM (RUBY) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2023 Q2 0 $0 -$61,308 0
2023 Q1 2,957,155 $61,308 -$10,517,874 $0.02 5
2022 Q4 65,434,344 $11,201,090 -$1,254,198 $0.18 38
2022 Q3 68,758,532 $29,676,971 -$5,584,089 $0.43 52
2022 Q2 78,337,002 $66,619,526 -$40,094,718 $0.85 68
2022 Q1 89,631,879 $493,862,969 +$653,119 $5.51 114
2021 Q4 89,207,458 $863,551,443 +$20,919,731 $9.68 105
2021 Q3 47,880,381 $856,518,394 +$11,429,092 $17.88 102
2021 Q2 47,063,988 $1,148,798,104 +$34,608,802 $24.41 106
2021 Q1 45,476,673 $1,205,199,236 +$228,807,941 $26.50 102
2020 Q4 37,090,842 $281,518,597 +$13,289,869 $7.59 85
2020 Q3 76,307,347 $382,382,446 -$5,601,572 $5.01 85
2020 Q2 77,271,729 $462,282,528 +$12,798,861 $5.98 83
2020 Q1 75,275,225 $334,978,279 -$48,128,612 $4.45 74
2019 Q4 81,132,770 $770,761,511 +$348,082,532 $9.50 75
2019 Q3 44,747,492 $351,269,788 +$17,073,481 $7.85 74
2019 Q2 40,001,461 $628,700,597 +$46,063,635 $15.73 68
2019 Q1 37,090,046 $671,319,786 +$111,094,651 $18.10 65
2018 Q4 69,244,543 $1,108,883,827 +$30,906,051 $16.08 56
2018 Q3 26,315,828 $619,950,408 +$619,949,162 $24.00 54